Drug Shortage Report for DEMYLOCAN
Report ID | 140576 |
Drug Identification Number | 02484811 |
Brand name | DEMYLOCAN |
Common or Proper name | Decitabine |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | |
Strength(s) | 50MG |
Dosage form(s) | POWDER |
Route of administration | INTRAVENOUS |
Packaging size | 20mL |
ATC code | L01BC |
ATC description | |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-04-28 |
Actual start date | 2021-04-28 |
Estimated end date | 2021-06-21 |
Actual end date | 2021-06-21 |
Shortage status | Resolved |
Updated date | 2021-06-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-06-08 | English | Compare |
v2 | 2021-06-08 | French | Compare |
v3 | 2021-06-15 | English | Compare |
v4 | 2021-06-15 | French | Compare |
v5 | 2021-06-17 | English | Compare |
v6 | 2021-06-17 | French | Compare |
v7 | 2021-06-21 | English | Compare |
v8 | 2021-06-21 | French | Compare |
v9 | 2021-06-22 | English | Compare |
Showing 1 to 9 of 9